COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1700: Articles 16991-17000  | Next

Sharing positive changes made during COVID-19 national lockdown: a multi-method co-production study
Williams, L., MacDonald, B., Rollins, L., Janssen, X., Fleming, L., Grealy, M., Kirk, A., Young, D., Flowers, P.
10.1101/2021.03.03.21252809 — Posted: 2021-03-05
Self-reported symptoms, self-reported viral testing result and seroprevalence of SARS CoV-2 among a community sample in Essex County New Jersey: A brief report.
Raymond, H. F., Datta, P., Ukey, R., Wang, P., Martino, R. J., Krause, K. D., Rosmarin-DeStefano, C., Pinter, A., Halkitis, P. N., Gennaro, M. L.
10.1101/2021.03.02.21252766 — Posted: 2021-03-05
Geographic disparities in COVID-19 case rates are not reflected in seropositivity rates using a neighborhood survey in Chicago
Mustanski, B., Saber, R., Ryan, D. T., Benbow, N., Madkins, K., Hayford, C., Newcomb, M. E., Schrock, J. M., Vaught, L. A., Reiser, N. L., Velez, M. P., Hsieh, R., Demonbreun, A. R., D'Aquila, R., McNally, E. M., McDade, T. W.
10.1101/2021.03.02.21252767 — Posted: 2021-03-05
Short-stay admissions and lower staffing associated with larger COVID-19 outbreaks in Maryland nursing homes
Mattingly, T. J., Trinkoff, A., Lydecker, A. D., Kim, J. J., Yoon, J. M., Roghmann, M.-C.
10.1101/2021.03.03.21252846 — Posted: 2021-03-05
Redesigning SARS-CoV-2 clinical RT-qPCR assays for wastewater RT-ddPCR
Gonzalez, R. A., Larson, A., Thompson, H., Carter, E., Cassi, X. F.
10.1101/2021.03.02.21252754 — Posted: 2021-03-05
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers
Lundstrom, A., Ziegler, L., Havervall, S., Rudberg, A.-S., Meijenfeldt, F. V., Lisman, T., Mackman, N., Sanden, P., Thalin, C.
10.1101/2021.03.03.21252841 — Posted: 2021-03-05
Virological and serological characterization of critically ill patient with COVID-19 in the UK: a special focus on variant detection
Ratcliff, J., Nguyen, D., Fish, M., Rhynne, J., Jennings, A., Williams, S., Al-Beidh, F., Bonsall, D., Ciccone, N., Evans, A., Golubchik, T., Gordon, A. C., Lamikanra, A., Laing, E., Leuscher, U., Mouncey, P. R., Olivera, M., Slack, W., Tsang, P., Ziyenge, S., Ploeg, R., Rowan, K. M., Shankar-Hari, M., Roberts, D., Menon, D. K., Estcourt, L., Simmonds, P., Harvala, H., REMAP-CAP Immunoglobulin Domain UK Investigators
10.1101/2021.02.24.21251989 — Posted: 2021-03-05
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, , Jha, P.
10.1101/2021.03.04.21252540 — Posted: 2021-03-05
COVID-19 test positivity: predictive value of various symptoms in a large community-based testing program in California
Miller, D. P., Morrow, S., Califf, R. M., Kaiser, C., Kapur, R., Starsiak, C., Mega, J., Marks, W. J.
10.1101/2021.03.03.21252014 — Posted: 2021-03-05
Association between SARS-CoV-2 Transmission Risk, Viral Load, and Age: A Nationwide Study in Danish Households
Lyngse, F. P., Molbak, K., Franck, K. T., Nielsen, C., Skov, R. L., Kirkeby, C. T.
10.1101/2021.02.28.21252608 — Posted: 2021-03-05 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).